| 2025 | A One Stone Three Birds Paradigm of Photon-Driven Pyroptosis Dye for Amplifying Tumor Immunotherapy | 윤주영 | Article |
| 2023 | Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials | 윤주영 | Review |
| 2026 | Cathepsin B-Cleavable Doxorubicin Prodrug Nanoparticles for Eliciting Cancer-Specific Immunogenic Cell Death and Minimizing Systemic Toxicity | 김진성; 유진하; 김광명 | Article |
| 2019 | Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma | 이수진 | Article |
| 2017 | Current immunotherapeutic strategies in hepatocellular carcinoma: Recent advances and future directions | 김희영; 김휘영 | Review |
| 2016 | Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression | 안영호 | Article |
| 2019 | LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target | 이수진 | Article |
| 2024 | Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors | 김광명 | Review |
| 2024 | Nanotechnology-Based Strategies for Safe and Effective Immunotherapy | 김광명 | Review |
| 2023 | Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer | 함아롱 | Article |
| 2023 | Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities | 김이준 | Review |
| 2022 | TcellInflamedDetector: an R package to distinguish T cell inflamed tumor types from non–T cell inflamed tumor types | 박현석 | Article |
| 2022 | Tumor Selective Metabolic Reprogramming as a Prospective PD-L1 Depression Strategy to Reactivate Immunotherapy | 윤주영 | Article |
